<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="2-part\PMC6921433\results\search\disease\results.xml">
  <result pre="for future outbreaks of emerging infectious diseases. Yet when an" exact="infectious disease" post="is emerging, there is often substantial risk and uncertainty"/>
  <result pre="to accelerate testing of interventions. One prominent example was the" exact="yellow fever" post="experiments conducted by Walter Reed and colleagues in the"/>
  <result pre="Reed and colleagues in the early 1900s that proved that" exact="yellow fever" post="was transmitted by mosquitoes [1]. Over the last few"/>
  <result pre="by mosquitoes [1]. Over the last few decades, controlled human" exact="malaria" post="infection studies have enrolled approximately 2000 participants, with no"/>
  <result pre="coordinate the development of new vaccines to prevent and contain" exact="infectious disease" post="epidemics�? [7]. For epidemics that loom on the horizon,"/>
  <result pre="to determine whether and when an HCT of an emerging" exact="infectious disease" post="could be permissible. Through this analysis, we isolate several"/>
  <result pre="it ethically acceptable to conduct an HCT on an emerging" exact="infectious disease." post="Recognizing that, for many high priority diseases, an HCT"/>
  <result pre="not limited to Guillain–Barré syndrome, which is an acute, progressive" exact="neuropathy" post="that can result in paralysis [10, 11]. It can"/>
  <result pre="can cause congenital Zika syndrome. Congenital Zika syndrome typically involves" exact="microcephaly" post="and potentially significant abnormalities in neurological development, visual impairment,"/>
  <result pre="other viruses in the same family (flaviviruses such as dengue," exact="yellow fever," post="West Nile) would have been an exclusion criterion for"/>
  <result pre="research with pregnant women), a neurologist, two obstetrician/gynecologists, and an" exact="infectious disease" post="physician. Panel members were vetted to ensure there were"/>
  <result pre="stakeholders are likely to be interested in addressing an emerging" exact="infectious disease" post="in the midst of an outbreak, making it difficult"/>
  <result pre="this exception was included in order not to condemn the" exact="yellow fever" post="HCTs conducted by Walter Reed and colleagues, in which"/>
  <result pre="the research team were enrolled, and one investigator died from" exact="yellow fever." post="However, because the Nuremberg Code’s statement does not provide"/>
  <result pre="HCTs: &quot;[A] study that involves deliberately infecting healthy individuals with" exact="anthrax" post="or Ebola - both of which pose a very"/>
  <result pre="Joffe and Miller give the example of an epidemic of" exact="avian influenza" post="and note that, just as firefighters or rescue workers"/>
  <result pre="and Miller give the example of an epidemic of avian" exact="influenza" post="and note that, just as firefighters or rescue workers"/>
  <result pre="[6]. Accordingly, another possible way an HCT on an emerging" exact="infectious disease" post="could be ethically acceptable is if the HCT was"/>
  <result pre="exposure to fetuses can be catastrophic [31]. If an emerging" exact="infectious disease" post="was not transmissible to fetuses, then, an HCT of"/>
  <result pre="not transmissible to fetuses, then, an HCT of an emerging" exact="infectious disease" post="might be easier to justify. Similarly, if a disease"/>
  <result pre="monitoring throughout the study, then an HCT on an emerging" exact="infectious disease" post="could be relatively straightforward to justify ethically (provided of"/>
  <result pre="to illustrate a possible use of HCT with an emerging" exact="infectious disease;" post="this is one way to flesh out the WHO’s"/>
  <result pre="illustrates a scenario in which an HCT on an emerging" exact="infectious disease" post="might be relatively straightforward to justify ethically because the"/>
  <result pre="Ecol201742220822210.1111/jvec.1226129125246 2.RoestenbergMHoogerwerfMAFerreiraDMMordmüllerBYazdanbakhshMExperimental infection of human volunteersLancet Infect Dis20181810e312e32210.1016/S1473-3099(18)30177-429891332 3.SpringMPolhemusMOckenhouseCControlled human" exact="malaria" post="infectionJ Infect Dis2014209Suppl 2S40S4510.1093/infdis/jiu06324872394 4.BeecherHKEthics and clinical researchN Engl"/>
  <result pre="Zika Virus Infection in ColombiaN Engl J Med2016375161513152310.1056/NEJMoa160556427705091 12.AlettiMLecoulesSKanczugaVSolerCMaquartMSimonFet al.Transient" exact="myocarditis" post="associated with acute Zika virus infectionClin Infect Dis201764567867927940942 13.de"/>
  <result pre="Health Department of Pernambuco. Association between Zika virus infection and" exact="microcephaly" post="in Brazil, January to May, 2016: Preliminary report of"/>
  <result pre="resource settings: Experiences and perceptions of study participants in a" exact="malaria" post="Challenge study in KenyaWellcome Open Research201833910.12688/wellcomeopenres.14439.229806038 40.StunkelLGradyCMore than the"/>
 </snippets>
</snippetsTree>
